Document is current
Any future updates will be listed below
-
Authors
Millá Griñó, Elena
Giménez Gómez, Rafael
Larrosa Poves, José Manuel
Vila Arteaga, Jorge
Asorey García, Almudena
Giacomini, Fernando
Vera, Vanessa
-
Funding
Funding for this research was provided by:
AbbVie S.L.U.
- License Information
-
More Information
Article History
Received: 16 October 2025
Accepted: 28 November 2025
First Online: 7 January 2026
Declarations
:
: Elena Millá Griñó: Received speaker fees from AbbVie, Santen, Brill, Viu 20/20, Glaukos, and Visufarma. Rafael Giménez Gómez has nothing to disclose. José M Larrosa Poves: Received speaker and consulting fees from AbbVie, Bausch & Lomb, and Santen. Jorge Vila Arteaga: Received speaker and consulting fees from AbbVie, Bausch & Lomb, Santen, and Glaukos. Almudena Asorey-García is an AbbVie employee and may own AbbVie stocks/options. Fernando Giacomini is an AbbVie employee and may own AbbVie stocks/options. Vanessa Vera is an AbbVie employee and may own AbbVie stocks/options.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
